At a glance
The July 26, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on the SARS-CoV-2 variants and genomic changes, as well as an FDA update.

Agenda
Welcome: Nancy Anderson, CDC Division of Laboratory Systems (DLS)
CDC Influenza SARS-CoV-2 Multiplex Assay: Brandi Limbago, CDC Laboratory and Testing Task Force for the COVID-19 Response
Genomic Changes Causing SARS-CoV-2 Detection Partial Failure: Daniel D. Rhoads, Cleveland Clinic
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)